Elevated expression of XIST was recently associated with poor survival in CRC patients, and knockdown of XIST inhibited proliferation, invasion, epithelial-mesenchymal transition (EMT) and CRC stem cell formation in vitro, as well as tumor growth and metastasis in vivo [182]. The gene discussed is XIST; the disease is colorectal carcinoma.